Guidant Strengthens Resolve To Build Vulnerable Plaque Market
This article was originally published in The Gray Sheet
Executive Summary
Guidant is backing its previously stated pledge to develop a market for the diagnosis and treatment of vulnerable plaque, investing in Miravant Medical Technologies' PhotoPoint photodynamic therapy